Julie Johnson sold Bristol-Myers Squibb Company (NYSE: BMY)
Julie Johnson (D-TX), a U.S. Representative, has disclosed 5 trades in Bristol-Myers Squibb Company (BMY) since 2025, 1 purchase and 4 sales, worth an estimated $40K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Julie Johnson sold $1,001 - $15,000 of Bristol-Myers Squibb Company (NYSE: BMY) on April 1, 2025. Since that trade, BMY is up +1.82% against the S&P 500 up +33.74%, an outperformance of -31.92%.
Across these filings, Julie Johnson has been a net seller of BMY (a buy-to-sell ratio of 0.25). The most recent disclosed BMY transaction shown was dated December 18, 2025. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Julie Johnson's BMY trades vs the price
BMY is up +1.82% since Julie Johnson sold on April 1, 2025, versus +33.74% for the S&P 500.
Performance since this trade
All Julie Johnson BMY trades
| Traded | Type | Size | Return | Est. profit | |
|---|---|---|---|---|---|
| December 18, 2025 | SELL | $52.17 | +9.51% | — | |
| November 13, 2025 | SELL | $47.57 | +20.09% | — | |
| August 14, 2025 | SELL | $46.14 | +23.83% | — | |
| April 1, 2025 | SELL | $56.11 | +1.82% | — | |
| January 15, 2025 | BUY | $52.68 | +8.45% | +$175 |
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Julie Johnson & BMY trading FAQ
Is it legal for Julie Johnson to trade Bristol-Myers Squibb Company (BMY) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Bristol-Myers Squibb Company (BMY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; this page does not imply the trade was improper.
When did Julie Johnson sell BMY?
Julie Johnson disclosed a sale of $1,001 - $15,000 of Bristol-Myers Squibb Company (BMY) on April 1, 2025, according to public STOCK Act filings.
How has BMY performed since Julie Johnson's trade?
Since Julie Johnson sold BMY on April 1, 2025, the stock is up +1.82%, versus +33.74% for the S&P 500 over the same period, an outperformance of -31.92%.
How many times has Julie Johnson traded BMY?
Julie Johnson has disclosed 5 BMY trades since 2025 (1 purchase and 4 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional BMY trades?
BullishWhales tracks every disclosed congressional trade in Bristol-Myers Squibb Company (BMY) on the Bristol-Myers Squibb Company congressional trading page, which aggregates filings across all members of Congress.
Julie Johnson's BMY tradesAll congressional filings for Bristol-Myers Squibb CompanyJulie Johnson's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.